RBM22 (Center), 165-193 Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-RBM22 (Center), 165-193 antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | RBM22 (Center), 165-193 |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human (predicted reactivity: bovine, chicken, zebrafish, monkey, mouse, rat, Xenopus) |
| Isotype | n/a |
| Format | peptide affinity purified |
| Size | 0.08 mL, 0.4 mL |
| Concentration | vial concentration: 0.38 |
| Applications | Western Blot (WB), ELISA (EIA), Immunohistochemistry (IHC) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | This RBM22 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 165-193 amino acids from the Central region of human RBM22. This gene encodes an RNA binding protein. The encodedprotein may play a role in cell division and may be involved inpre-mRNA splicing. Related pseudogenes exist on chromosomes 6, 7,9, 13, 16, 18, and X. |
| Immunogen | n/a |
| Other Names | [Pre-mRNA-splicing factor RBM22; RNA-binding motif protein 22; Zinc finger CCCH domain-containing protein 16; RBM22; ZC3H16] |
| Gene, Accession # | [RBM22], Gene ID: 55696, NCBI: NP_060517.1, UniProt: Q9NW64 |
| Catalog # | MBS9209504 |
| Price | $165, $370 |
| Order / More Info | RBM22 (Center), 165-193 Antibody from MYBIOSOURCE INC. |
| Product Specific References | Krebs, J. Biochim. Biophys. Acta 1793(6):979-984(2009) Satoh, J., et al. Neuropathol. Appl. Neurobiol. 35(1):16-35(2009) He, F., et al. Genet. Mol. Res. 8(4):1466-1473(2009) Montaville, P., et al. Biochim. Biophys. Acta 1763(11):1335-1343(2006) Kittler, R., et al. Nature 432(7020):1036-1040(2004) |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies